Brandon Glenn

Although the compensation structure for venture capital funds may not be ideal, it does not appear to be changing anytime soon. Read more about the pros and cons of the VC pay model.

Getting government funding can be difficult for life sciences startups, but it can be done. Read more for tips on how to get SBIR and STTR grants.

Accelerators provide lots of helpful things to startups, but don't really generate venture capital returns, according to a recent panel. Read more about the discussion.

Healthcare investing by venture capitalists dropped to its lowest level in five quarters, but the decrease follows a five-quarter high. Read more for details.

While business incubators have gained popularity, one CEO is offering an alternative that he says is better. Read more about the pitfalls of incubators.

Angel investors put more money into healthcare than any other industry last year. Read more about why angel investors are favoring healthcare startups, especially medical device startups.

Young biotech companies sometimes face a valley of death in funding, but a venture capital researcher is challenging that idea. Read more about the early stage funding valley of death.

Early stage company entrepreneurs have been warned about a "valley of death" for funding. Read about whether it's real or just a myth.

Starting a biotech or pharma business is easier with advice from those who have tried it. Read more about the books that share the successes and failures of biotech and pharma entrepreneurs.

Venture capital investment in healthcare startups increased last year in the Midwest, but the dollar amount raised lags behind earlier years. Read more about the state of venture capital investing in healthcare startups.